← Back to Search

Other

Amount of Celastrol Administered for Safety Concerns

N/A
Waitlist Available
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights
No Placebo-Only Group

Summary

This trial involves healthy men aged 18-40 taking increasing doses of celastrol to see how it affects their sperm count and movement. The study will measure changes in sperm over time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amount of Sperm in 1 mL of Ejaculate after Celastrol Ingestion
Motility of Sperm in 1 mL of Ejaculate after Celastrol Ingestion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Increasing doses of Celastrol to each of five male subjects

Find a Location

Who is running the clinical trial?

Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
35 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorLegend Labz, Inc.
1 Previous Clinical Trials
35 Total Patients Enrolled
~1 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top